tiprankstipranks
Context Therapeutics (CNTX)
NASDAQ:CNTX
US Market

Context Therapeutics (CNTX) Income Statement

Compare
105 Followers

Context Therapeutics Income Statement

Last quarter (Q3 2024), Context Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Context Therapeutics's net income was $-17.46M. See Context Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -12.04K$ -9.27K$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 25.07M$ 14.88M$ 7.44M$ 2.57M$ 5.38M
Depreciation and Amortization
$ 12.04K$ 9.27K$ -3.09M$ 2.57M$ 5.38M
EBITDA
$ -25.06M$ -14.83M$ -10.53M$ 0.00$ 0.00
Operating Income
$ -25.07M$ -15.38M$ -10.53M$ -2.57M$ -5.38M
Other Income/Expenses
$ 1.11M$ 545.26K$ 68.95K$ 9.22M$ -1.01M
Pretax Income
$ -23.96M$ -14.84M$ -10.46M$ 6.64M$ -6.38M
Net Income
$ -23.96M$ -14.29M$ -7.43M$ 6.64M$ -7.48M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.50$ -0.90$ -0.47$ 0.61$ -0.68
Diluted EPS
$ -1.50$ -0.90$ -0.47$ 0.61$ -0.68
Weighted Average Shares Outstanding
15.97M 15.97M 15.97M 10.96M 10.96M
Weighted Average Shares Outstanding (Diluted)
15.97M 15.97M 15.97M 10.96M 10.96M
Currency in USD

Context Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis